In 2021, the endoscopic retrograde cholangiopancreatography market was worth around USD 1,270.9 million, and it is projected to advance at an 8.1% CAGR from 2021 to 2030, hitting USD 2,557.7 million by 2030, according to P&S Intelligence. This growth can be credited to the growth in the occurrence of pancreatic cancer and a paradigm move toward minimally invasive procedures. In … Continua a leggere→